These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7018774)

  • 1. Demonstration of a passive Heymann nephritis-like mechanism in a human kidney transplant.
    Zanetti M; Mandet C; Duboust A; Bedrossian J; Bariety J
    Clin Nephrol; 1981 May; 15(5):272-7. PubMed ID: 7018774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats.
    Salant DJ; Belok S; Stilmant MM; Darby C; Couser WG
    Lab Invest; 1979 Jul; 41(1):89-99. PubMed ID: 376941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephritogenic and non-nephritogenic epithelial antigens in autoimmune and passive Heymann nephritis.
    Miettinen A; Törnroth T; Ekblom P; Virtanen I; Linder E
    Lab Invest; 1984 Apr; 50(4):435-46. PubMed ID: 6708453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe glomerular epithelial cell damage does not prevent passive Heyman nephritis in rats.
    Bertani T; Remuzzi G; Poggi A; Delaini F; Sacchi G; Morassi L; Verroust P; Mecca G; Donati MB
    Clin Exp Immunol; 1983 Jan; 51(1):38-44. PubMed ID: 6339125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies with monoclonal antibodies against brush border antigens in Heymann nephritis.
    Bhan AK; Schneeberger EE; Baird LG; Collins AB; Kamata K; Bradford D; Erikson ME; McCluskey RT
    Lab Invest; 1985 Oct; 53(4):421-32. PubMed ID: 3900581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular pathology of Heyman nephritis: monoclonal antibodies against the pathogenic antigen Gp 330].
    Kerjaschki D
    Wien Klin Wochenschr; 1985 Jul; 97(14):581-8. PubMed ID: 3901534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific uptake of Heymann's nephritic kidney eluate by rat kidney: studies in vivo and in isolated perfused kidneys.
    Neale TJ; Couser WG; Salant DJ; Lowenstein LM; Wilson CB
    Lab Invest; 1982 Apr; 46(4):450-3. PubMed ID: 7040800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of circulating autoantibody levels in the rat with established progressive passive Heymann nephritis.
    Barabas AZ; Cornish J; Lannigan R
    Clin Exp Immunol; 1986 Jul; 65(1):34-41. PubMed ID: 3539426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent and de novo membranous glomerulonephritis in renal cadaver allotransplants.
    Briner J; Binswanger U; Largiadèr F
    Clin Nephrol; 1980 Apr; 13(4):189-96. PubMed ID: 6991185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of an anaphylactic vasopermeability mechanism for immune complex deposition in the Heymann nephritis of rats.
    Egido J; Alonso F; Sanchez Crespo M; Barat A; Hernando L
    Clin Exp Immunol; 1980 Oct; 42(1):99-106. PubMed ID: 6161727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity of a highly purified brush border membrane preparation in Heymann nephritis.
    Chant S; Katz A; Silverman M
    J Clin Lab Immunol; 1980 Nov; 4(3):133-40. PubMed ID: 6451709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic nephritis induced by antibodies reacting with glomerular-bound immune complexes.
    van Es LA; Blok AP; Schoenfield L; Glassock RJ
    Kidney Int; 1977 Feb; 11(2):106-15. PubMed ID: 321857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephritogenic antibodies against kidney brush border glycoproteins in rabbits injected with Freund's adjuvant.
    Miettinen A
    Lab Invest; 1982 Jul; 47(1):67-75. PubMed ID: 7087399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Etiopathogenesis of membranous nephropathy: is there a correlation between experimental and human pathology?].
    Allegri L; Celendo MT; Savazzi G; Garini G; Carnevali ML
    Ann Ital Med Int; 1989; 4(4):386-95. PubMed ID: 2487793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous immune complex nephritis in rats. Influence of modification of mononuclear phagocyte system function.
    Abrass CK
    Lab Invest; 1984 Aug; 51(2):162-71. PubMed ID: 6611451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating immune complexes in rats with autologous immune complex nephritis.
    Abrass CK; Border WA; Glassock RJ
    Lab Invest; 1980 Jul; 43(1):18-27. PubMed ID: 6446622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Formation of immune deposits during experimental extramembranous glomerulonephritis].
    Verroust P; Ronco P
    Nephrologie; 1989; 10(3):123-6. PubMed ID: 2691908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genesis of glomerulonephritis in renal transplants.
    Merrill JP
    Adv Nephrol Necker Hosp; 1971; 1():65-73. PubMed ID: 5006259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.